Abstract
The Institute for Clinical and Economic Review’s (ICER’s) Evidence Rating Matrix is a comparative clinical effectiveness decision tool that distills an intervention’s net health benefit and its uncertainty into ordered categorical grades. ICER assessments also estimate incremental lifetime quality-adjusted life years (QALYs) through cost-effectiveness modeling. This analysis aims to explore the relationship between ICER’s Evidence Rating Matrix and incremental QALYs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
